| For: | Wang XL, Yang M, Wang Y. Roles of transforming growth factor-β signaling in liver disease. World J Hepatol 2024; 16(7): 973-979 [PMID: 39086528 DOI: 10.4254/wjh.v16.i7.973] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v16/i7/973.htm |
| Number | Citing Articles |
| 1 |
Ola Alsharif, Krista Rombouts. Mechanisms of orphan nuclear receptor Nur77 in liver health, disease, and therapeutic potential: narrative review. npj Gut and Liver 2025; 2(1) doi: 10.1038/s44355-025-00037-9
|
| 2 |
Friedrich Reusswig, Carsten Deppermann. The Role of Platelets Beyond Hemostasis. Hämostaseologie 2026; 46(01) doi: 10.1055/a-2755-7600
|
| 3 |
Palak Kumar, Pranshuta Rawat, Mehfooz Helal, Abhishek Sharma, Jhansi Magisetty, Vijay Kondreddy. Decoding circRNA–miRNA crosstalk in the pathogenesis of hepatic fibrosis: A comprehensive review. International Journal of Biological Macromolecules 2026; 371 doi: 10.1016/j.ijbiomac.2026.153022
|
| 4 |
Nakul Mahajan, Nazdeep Kaur, Samar Pal S Sandhu, Vyoma Patel, Hunardeep Kaur Boparai, Kanwarmandeep Singh, FNU Rajinderpal Singh. Fibrosis-Driven Cardiovascular Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease: Emerging Links With Atherosclerotic Cardiovascular Disease. Cureus 2026; doi: 10.7759/cureus.115501
|
| 5 |
Maryam Jadid Tavaf, Saeid Abroun, Mahdieh Hashemi, Ibrahim Ghoytasi, Abbas Piryaei, Masoud Soleimani, Ali Zarrabi, Massoud Vosough. Cord-blood-PRP attenuates fibrogenic features of TGFβ-activated hepatic stellate cells in in vitro and animal models. Bioorganic Chemistry 2026; 174 doi: 10.1016/j.bioorg.2026.109748
|
| 6 |
Mi Zhou, Jianyu Lv, Xinli Chen, Yujie Shi, Guanqun Chao, Shuo Zhang. From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2025.101777
|
| 7 |
Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, Yoav I. Henis. Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1580500
|
| 8 |
Tianqi Yu, Zhihao Fang, Yue Cheng, Yongxu Zhou, Yanchao Ji, Chang Liu. A novel palmitoylation-based molecular signature reveals COX6A1 as a key regulator in metabolic dysfunction-associated steatotic liver disease. Journal of Translational Medicine 2025; 23(1) doi: 10.1186/s12967-025-07253-0
|
| 9 |
Giorgio Cazzaniga, Francesca Bolis, Chiara Caime, Rocco Piazza, Laura Žigutytė, Jakob Nikolas Kather, Fabio Pagni, Pietro Invernizzi, Marco Carbone, Alessio Gerussi. Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies. Liver International 2025; 45(11) doi: 10.1111/liv.70377
|
| 10 |
Iulia Cristina Marginean, Sergiu Marian Cazacu, Cristina Maria Marginean, Mihaela Popescu, George Alexandru Iacob, Marian Sorin Popescu, Cristin Constantin Vere. When Atrial Fibrillation Meets Alcoholic Liver Cirrhosis: Can Direct Oral Anticoagulants Bridge the Therapeutic Gap?. Biomedicines 2026; 14(3) doi: 10.3390/biomedicines14030531
|
| 11 |
O. V. Kurbatova, G. B. Movsisyan, A. A. Zhuzhula, M. A. Snovskaya, S. V. Petrichuk, T. V. Radygina, M. V. Konyashin, E. L. Semikina, A. S. Potapov, D. V. Parakhina, A. P. Fisenko. Serum markers of fibrosis in autoimmune hepatitis in children. Russian Journal of Immunology 2026; 29(3) doi: 10.46235/1028-7221-17446-SMO
|
| 12 |
Gehan R. Abdel-Hamid, Ahmed Hammad, Hayam Mostafa, Dalia E. El-Nashar, Assmaa Fathi Abd Elkhalek, Eman S. Eldin, Monda M.M Badawy. 5-Fluorouracil loaded nanogels attenuate hepatotoxicity by modulating PI3K/AKT, NF-κB, and METTL14 pathways. Asian Pacific Journal of Tropical Biomedicine 2026; 16(7) doi: 10.4103/apjtb.apjtb_185_26
|
| 13 |
Manali Patel, Suhani Wadhwa, Devanshi Parmar, Hiral Aghara, Palash Mandal, Anuja Salgaonkar. Short‐Chain Fatty Acids Linking the Gut–Liver Axis to Steatotic Liver Disease and Fibrogenesis. Mediators of Inflammation 2026; 2026(1) doi: 10.1155/mi/5761941
|
| 14 |
Md Shariful Islam, Md Monirul Islam, Abu Amer Hisham, SM Tanjil Shah, Md Arafat Al Mamun, Mohammad Salim Hossain. Bioactive Metabolites from Lactobacillus acidophilus-Fermented Products Mitigate Carbon Tetrachloride–Induced Liver Injury: Biochemical and In Silico Insights. Current Developments in Nutrition 2026; 10(2) doi: 10.1016/j.cdnut.2026.107648
|
| 15 |
Jiyoung Heo, Dong-Hoon Chae, Hyun Sung Park, Aaron Yu, Jae Han Park, Keonwoo Cho, Jiho Kim, Hyewon Lee, Sueyeon Jee, Chanwoo Kim, Dasom Kong, Yoojin Seo, Hyung-Sik Kim, Dongha Bhang, Ki-Sun Park, Mi-Kyung Oh, Kyung-Rok Yu. Disease-derived liver organoids as a preclinical screening platform identify Sargassum japonica as an anti-fibrotic candidate. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-43852-7
|
| 16 |
Meiyu Bi, Bai Dai, Rina Sha, Xiyan Hao, Xin Chen, Chen Du, Zhimin Wang. miR‐204‐5p Promotes Hepatogenic Differentiation of Adipose‐Derived Stem Cells to Ameliorate Acute Liver Failure via the MDM2/E2F8/BMP4 Axis. The FASEB Journal 2026; 40(12) doi: 10.1096/fj.202504415RR
|
| 17 |
Aya M. Eid, Ahmed O. El-Gendy, Mohamed Gamal El-Din Ewees. Vildagliptin attenuates the development of CCl₄-induced liver fibrosis: associations with gut–liver axis modulation and LPS/notch-related signaling. Naunyn-Schmiedeberg's Archives of Pharmacology 2026; doi: 10.1007/s00210-026-05961-y
|
| 18 |
Sahar Saki, Sajad Monjezi, Fatemeh Ghaffari, Ghazal Orak, Samaneh Salehipour Bavarsad, Azam Khedri, Mahdi Hatami. Unraveling the Exosome-miR-133a Axis: Targeting TGF-β Signaling via WJ-MSC-Derived Exosomes for Anti-Fibrotic Therapy in Liver Fibrosis. Iranian Biomedical Journal 2024; 28(5) doi: 10.61186/ibj.4357
|
| 19 |
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis. Immune Checkpoints and the Immunology of Liver Fibrosis. Livers 2025; 5(1) doi: 10.3390/livers5010005
|
| 20 |
Di Zeng, Saud Ahmad Saad, Jiong Lu, Zhen You, Bei Li. Systemic inflammation and liver fibrosis as predictors of surgical outcomes in colorectal cancer liver metastasis: a biomarker-based survival study. Updates in Surgery 2026; doi: 10.1007/s13304-025-02504-7
|
| 21 |
Deyaa A. Shaban, Ahmed A. G. El-Shahawy, Mohamed I. Zanaty, Zienab E. Eldin, Mohamed Abd-Elbaset, Anwar Shams, Shadi Tamur, Osama M. Ahmed. Utilizing Nanoparticles of Hesperidin Loaded on Layered Double Hydroxide to Reduce Hepatotoxicity Caused by Paracetamol in Rats: Controlling of Biotransformation, Oxidative Stress, Inflammation, and Apoptosis. Pharmaceutics 2025; 17(4) doi: 10.3390/pharmaceutics17040429
|
| 22 |
Konstantinos Manganas, Sophia Delicou, Emilia Hadziyannis, Stavroula Giannouli, John Koskinas. Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease. International Journal of Hematology 2025; 122(5) doi: 10.1007/s12185-025-04035-8
|
| 23 |
Satya Priya Sharma, Min-Gi Cha, Goo-Hyun Kwon, Seol Hee Song, Jeong Ha Park, Min Ju Kim, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Hyunjoon Park, Sung-Min Won, Ki-Kwang Oh, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Ki Tae Suk. Phocaeicola plebeius oral treatment improve fibrosis by reversing cirrhosis-related hepatic gene dysregulation. Life Sciences 2025; 381 doi: 10.1016/j.lfs.2025.123979
|
| 24 |
Joana Ferreira, João Caldeira, Manuel Bicho, Paula Faustino, Fátima Serejo. Hepatitis C Virus: An Overview of Its Chronic Impact on Liver Function, Metabolic Dysregulation, Inflammatory–Oxidative Pathogenesis and Epigenetic Memory. International Journal of Molecular Sciences 2026; 27(8) doi: 10.3390/ijms27083559
|
| 25 |
Jeong-Hoo Lee, Je-Hyun Eom, Seung-Jo Yang, Jiyoung Hwang, Jam-Eon Park, Seung-Hwan Park, Young-Youn Kim, Hye-Sung Kim. A Probiotic Combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 Improves Glycemic Control and Insulin Resistance in High-Fat-Diet-Induced Obese Mice. Nutrients 2026; 18(13) doi: 10.3390/nu18132107
|